BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 17579026)

  • 1. The inositol 5'-phosphatase SHIP-2 negatively regulates IgE-induced mast cell degranulation and cytokine production.
    Leung WH; Bolland S
    J Immunol; 2007 Jul; 179(1):95-102. PubMed ID: 17579026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
    Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
    J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase.
    Huber M; Hughes MR; Krystal G
    J Immunol; 2000 Jul; 165(1):124-33. PubMed ID: 10861044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
    Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
    J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Notch signaling enhances FcεRI-mediated cytokine production by mast cells through direct and indirect mechanisms.
    Nakano N; Nishiyama C; Yagita H; Hara M; Motomura Y; Kubo M; Okumura K; Ogawa H
    J Immunol; 2015 May; 194(9):4535-44. PubMed ID: 25821223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells.
    Ruschmann J; Antignano F; Lam V; Snyder K; Kim C; Essak M; Zhang A; Lin AH; Mali RS; Kapur R; Krystal G
    J Immunol; 2012 Apr; 188(8):3839-50. PubMed ID: 22430739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of Lyn kinase A and B isoforms reveals redundant and distinct roles in Fc epsilon RI-dependent mast cell activation.
    Alvarez-Errico D; Yamashita Y; Suzuki R; Odom S; Furumoto Y; Yamashita T; Rivera J
    J Immunol; 2010 May; 184(9):5000-8. PubMed ID: 20308635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of SHIP in mast cell degranulation and IgE-induced mast cell survival.
    Huber M; Kalesnikoff J; Reth M; Krystal G
    Immunol Lett; 2002 Jun; 82(1-2):17-21. PubMed ID: 12008029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells.
    Hernandez-Hansen V; Smith AJ; Surviladze Z; Chigaev A; Mazel T; Kalesnikoff J; Lowell CA; Krystal G; Sklar LA; Wilson BS; Oliver JM
    J Immunol; 2004 Jul; 173(1):100-12. PubMed ID: 15210764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SHIP represses mast cell activation and reveals that IgE alone triggers signaling pathways which enhance normal mast cell survival.
    Kalesnikoff J; Lam V; Krystal G
    Mol Immunol; 2002 Sep; 38(16-18):1201-6. PubMed ID: 12217384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2 domain-containing inositol polyphosphate 5'-phosphatase is the main mediator of the inhibitory action of the mast cell function-associated antigen.
    Xu R; Abramson J; Fridkin M; Pecht I
    J Immunol; 2001 Dec; 167(11):6394-402. PubMed ID: 11714805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted disruption of SHIP leads to Steel factor-induced degranulation of mast cells.
    Huber M; Helgason CD; Scheid MP; Duronio V; Humphries RK; Krystal G
    EMBO J; 1998 Dec; 17(24):7311-9. PubMed ID: 9857188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-aggregation of FcgammaRII with FcepsilonRI on human mast cells inhibits antigen-induced secretion and involves SHIP-Grb2-Dok complexes.
    Kepley CL; Taghavi S; Mackay G; Zhu D; Morel PA; Zhang K; Ryan JJ; Satin LS; Zhang M; Pandolfi PP; Saxon A
    J Biol Chem; 2004 Aug; 279(34):35139-49. PubMed ID: 15151996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SHIP down-regulates FcepsilonR1-induced degranulation at supraoptimal IgE or antigen levels.
    Gimborn K; Lessmann E; Kuppig S; Krystal G; Huber M
    J Immunol; 2005 Jan; 174(1):507-16. PubMed ID: 15611277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation.
    Huber M; Helgason CD; Damen JE; Liu L; Humphries RK; Krystal G
    Proc Natl Acad Sci U S A; 1998 Sep; 95(19):11330-5. PubMed ID: 9736736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation.
    Leitges M; Gimborn K; Elis W; Kalesnikoff J; Hughes MR; Krystal G; Huber M
    Mol Cell Biol; 2002 Jun; 22(12):3970-80. PubMed ID: 12024011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gab2, via PI-3K, regulates ARF1 in FcεRI-mediated granule translocation and mast cell degranulation.
    Nishida K; Yamasaki S; Hasegawa A; Iwamatsu A; Koseki H; Hirano T
    J Immunol; 2011 Jul; 187(2):932-41. PubMed ID: 21653832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
    Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
    J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of CD200 inhibition of mast cell activation.
    Zhang S; Cherwinski H; Sedgwick JD; Phillips JH
    J Immunol; 2004 Dec; 173(11):6786-93. PubMed ID: 15557172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
    Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
    J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.